To evaluate the role of RASSF7 in NSCLC progression in vivo, nude mice were subcutaneously or intravenously injected with cells transfected with a negative control vector, full-length RASSF7, or RASSF7-Mut4 construct. The gene discussed is RASSF7; the disease is non-small cell lung carcinoma.